These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 2124715

  • 1. Gastroduodenal ulcers in rats induced by 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): requirement for gastric acid secretion and the role of prostaglandins.
    Keshavarzian A, Haydek JM, Zepeda DO, Stinneford JG, Fields JZ.
    Res Commun Chem Pathol Pharmacol; 1990 Oct; 70(1):21-48. PubMed ID: 2124715
    [Abstract] [Full Text] [Related]

  • 2. [An animal model of peptic ulcer induced by destruction of dopaminergic neurons].
    Deng XY, Zheng ZT.
    Zhonghua Nei Ke Za Zhi; 1994 May; 33(5):313-6. PubMed ID: 7835142
    [Abstract] [Full Text] [Related]

  • 3. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
    Nishida A, Takinami Y, Yuki H, Kobayashi A, Akuzawa S, Kamato T, Ito H, Yamano M, Nagakura Y, Miyata K.
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
    [Abstract] [Full Text] [Related]

  • 4. [Monoamine concentrations in experimental ulcers in rats].
    Deng X, Gen Q, Zheng Z.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Jun; 18(3):229-33. PubMed ID: 9388998
    [Abstract] [Full Text] [Related]

  • 5. Effects of the novel anti-ulcer agent 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine on experimental ulcers and gastric secretion in rats.
    Tanaka T, Bickel M, Herling AW, Sakurai M, Goto M, Hayashi S.
    Arzneimittelforschung; 1989 Jun; 39(6):689-94. PubMed ID: 2775336
    [Abstract] [Full Text] [Related]

  • 6. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G, Hopkins A, Akbar FA.
    Postgrad Med J; 1988 Jun; 64 Suppl 1():60-77. PubMed ID: 3138682
    [Abstract] [Full Text] [Related]

  • 7. Helicobacter pylori infection and gastric secretion in duodenal and gastric ulcer patients--the effect of eradication after one year.
    Laszewicz W, Zaremba-Woroniecka A, Gabryelewicz A.
    J Physiol Pharmacol; 1997 Sep; 48(3):353-64. PubMed ID: 9376618
    [Abstract] [Full Text] [Related]

  • 8. Gastric acid secretion in Thai patients with particular reference to the characteristics differentiating types of gastric and duodenal ulcer.
    Manatsathit S, Kachintorn U, Boonyapisit S, Loengrojanakul P, Tanwandee T, Chinapak O.
    J Med Assoc Thai; 1993 Dec; 76(12):677-82. PubMed ID: 7798819
    [Abstract] [Full Text] [Related]

  • 9. The effect of different prostaglandins on cysteamine-induced duodenal ulcer in the rat.
    Náfrádi J, Bálint GA, Varró V.
    Acta Physiol Hung; 1984 Dec; 64(3-4):339-41. PubMed ID: 6397967
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of prostanoids in the treatment of gastric ulcer.
    Rachmilewitz D.
    Clin Invest Med; 1987 May; 10(3):238-42. PubMed ID: 3113800
    [Abstract] [Full Text] [Related]

  • 11. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
    Amagase K, Kato S, Yamamoto H, Okabe S.
    Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
    [Abstract] [Full Text] [Related]

  • 12. Evidence for the involvement of dopamine agonists and antagonists in duodenal ulcer disease.
    Neumeyer JL, Szabo S.
    Klin Wochenschr; 1986 Feb; 64 Suppl 7():123-7. PubMed ID: 3494157
    [Abstract] [Full Text] [Related]

  • 13. Effect of centrally administered oxytocin on gastric and duodenal ulcers in rats.
    Asad M, Shewade DG, Koumaravelou K, Abraham BK, Vasu S, Ramaswamy S.
    Acta Pharmacol Sin; 2001 Jun; 22(6):488-92. PubMed ID: 11747752
    [Abstract] [Full Text] [Related]

  • 14. The role of gastric and duodenal pH in the cysteamine-induced duodenal ulcer in the rat.
    Kusterer K, Rohr G, Herrmann W, Piplack C, Schwedes U, Usadel KH, Szabo S.
    Acta Physiol Hung; 1989 Jun; 73(2-3):247-50. PubMed ID: 2596314
    [Abstract] [Full Text] [Related]

  • 15. Effects of 5-acetylspiro[benzofuran-2(3H),1'-cyclopropan]-3-one, a new anti-ulcer agent, on experimental acute and chronic ulcers.
    Inatomi N, Hirata T, Inada I, Satoh H, Sino A, Maki Y.
    Arzneimittelforschung; 1985 Jun; 35(10):1553-9. PubMed ID: 4074415
    [Abstract] [Full Text] [Related]

  • 16. MPTP-induced duodenal ulcers in rat. Prevention by reuptake blockers for serotonin and norepinephrine, but not dopamine.
    Keshavarzian A, Wibowo A, Gordon JH, Fields JZ.
    Gastroenterology; 1990 Mar; 98(3):554-60. PubMed ID: 2298362
    [Abstract] [Full Text] [Related]

  • 17. Misoprostol and gastroduodenal mucosal protection (cytoprotection).
    Wilson DE.
    Postgrad Med J; 1988 Mar; 64 Suppl 1():7-11. PubMed ID: 3138683
    [Abstract] [Full Text] [Related]

  • 18. [Present position in the prevention and therapy of NSAID-induced ulcers].
    Lehmann FS, Beglinger C.
    Schweiz Med Wochenschr; 1999 Jul 27; 129(29-30):1073-80. PubMed ID: 10464910
    [Abstract] [Full Text] [Related]

  • 19. Roles of endogenous prostaglandins and cyclooxygenase izoenzymes in mucosal defense of inflamed rat stomach.
    Takeeda M, Hayashi Y, Yamato M, Murakami M, Takeuchi K.
    J Physiol Pharmacol; 2004 Mar 27; 55(1 Pt 2):193-205. PubMed ID: 15082878
    [Abstract] [Full Text] [Related]

  • 20. Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group.
    Bocanegra TS, Weaver AL, Tindall EA, Sikes DH, Ball JA, Wallemark CB, Geis GS, Fort JG.
    J Rheumatol; 1998 Aug 27; 25(8):1602-11. PubMed ID: 9712107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.